annual CFO:
-$116.64M-$37.15M(-46.73%)Summary
- As of today (June 17, 2025), GPCR annual cash flow from operations is -$116.64 million, with the most recent change of -$37.15 million (-46.73%) on December 31, 2024.
- During the last 3 years, GPCR annual CFO has fallen by -$84.48 million (-262.67%).
- GPCR annual CFO is now -716.61% below its all-time high of -$14.28 million, reached on December 1, 2020.
Performance
GPCR Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$52.23M-$15.76M(-43.22%)Summary
- As of today (June 17, 2025), GPCR quarterly cash flow from operations is -$52.23 million, with the most recent change of -$15.76 million (-43.22%) on March 31, 2025.
- Over the past year, GPCR quarterly CFO has dropped by -$18.15 million (-53.25%).
- GPCR quarterly CFO is now -417.37% below its all-time high of -$10.10 million, reached on June 1, 2022.
Performance
GPCR quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$134.78M-$18.15M(-15.56%)Summary
- As of today (June 17, 2025), GPCR TTM cash flow from operations is -$134.78 million, with the most recent change of -$18.15 million (-15.56%) on March 31, 2025.
- Over the past year, GPCR TTM CFO has dropped by -$41.52 million (-44.53%).
- GPCR TTM CFO is now -897.08% below its all-time high of -$13.52 million, reached on March 1, 2022.
Performance
GPCR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GPCR Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.7% | -53.3% | -44.5% |
| 3 y3 years | -262.7% | -286.4% | -897.1% |
| 5 y5 years | -716.6% | - | - |
GPCR Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -262.7% | at low | -417.4% | at low | -470.8% | at low |
| 5 y | 5-year | -716.6% | at low | -417.4% | at low | -897.1% | at low |
| alltime | all time | -716.6% | at low | -417.4% | at low | -897.1% | at low |
GPCR Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$52.23M(+43.2%) | -$134.78M(+15.6%) |
| Dec 2024 | -$116.64M(+46.7%) | -$36.47M(+85.1%) | -$116.64M(+14.5%) |
| Sep 2024 | - | -$19.70M(-25.4%) | -$101.90M(-0.8%) |
| Jun 2024 | - | -$26.39M(-22.6%) | -$102.76M(+10.2%) |
| Mar 2024 | - | -$34.08M(+56.8%) | -$93.26M(+17.3%) |
| Dec 2023 | -$79.49M | -$21.73M(+5.7%) | -$79.49M(+13.9%) |
| Sep 2023 | - | -$20.56M(+21.7%) | -$69.78M(+16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$16.89M(-16.8%) | -$59.71M(+12.9%) |
| Mar 2023 | - | -$20.31M(+68.9%) | -$52.91M(+14.7%) |
| Dec 2022 | -$46.12M(+43.4%) | -$12.03M(+14.7%) | -$46.12M(+35.3%) |
| Sep 2022 | - | -$10.48M(+3.8%) | -$34.09M(+44.4%) |
| Jun 2022 | - | -$10.10M(-25.3%) | -$23.61M(+74.7%) |
| Mar 2022 | - | -$13.52M | -$13.52M |
| Dec 2021 | -$32.16M(+125.2%) | - | - |
| Dec 2020 | -$14.28M | - | - |
FAQ
- What is Structure Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Structure Therapeutics?
- What is Structure Therapeutics annual CFO year-on-year change?
- What is Structure Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Structure Therapeutics?
- What is Structure Therapeutics quarterly CFO year-on-year change?
- What is Structure Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Structure Therapeutics?
- What is Structure Therapeutics TTM CFO year-on-year change?
What is Structure Therapeutics annual cash flow from operations?
The current annual CFO of GPCR is -$116.64M
What is the all time high annual CFO for Structure Therapeutics?
Structure Therapeutics all-time high annual cash flow from operations is -$14.28M
What is Structure Therapeutics annual CFO year-on-year change?
Over the past year, GPCR annual cash flow from operations has changed by -$37.15M (-46.73%)
What is Structure Therapeutics quarterly cash flow from operations?
The current quarterly CFO of GPCR is -$52.23M
What is the all time high quarterly CFO for Structure Therapeutics?
Structure Therapeutics all-time high quarterly cash flow from operations is -$10.10M
What is Structure Therapeutics quarterly CFO year-on-year change?
Over the past year, GPCR quarterly cash flow from operations has changed by -$18.15M (-53.25%)
What is Structure Therapeutics TTM cash flow from operations?
The current TTM CFO of GPCR is -$134.78M
What is the all time high TTM CFO for Structure Therapeutics?
Structure Therapeutics all-time high TTM cash flow from operations is -$13.52M
What is Structure Therapeutics TTM CFO year-on-year change?
Over the past year, GPCR TTM cash flow from operations has changed by -$41.52M (-44.53%)